AXONIS Therapeutics
Jennifer Burg is an accomplished clinical development professional with extensive experience in leadership roles within the biotechnology sector. Currently serving as the Senior Vice President of Clinical Development Operations at Axonis Therapeutics, Jennifer also operates as the Principal Consultant at Burg Consulting Group LLC. Previous positions include Vice President and Head of Clinical Operations at Stealth Biotech PBC, and Vice President of Program Management and Operations at Dyne Therapeutics. Additionally, Jennifer held the role of Vice President and Senior Director of Clinical Development Operations at Praxis Precision Medicines, Inc. Jennifer holds a Bachelor of Arts in Biology from Boston University, obtained in 2006.
This person is not in any teams
This person is not in any offices
AXONIS Therapeutics
AXONIS Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system.